Indications - Retapamulin is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm 2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes. Safety in patients younger than 9 months has not been established. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Retapamulin and other antibacterial drugs, Retapamulin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
Dosage & Administration - A thin layer of Topibac should be applied to the affected area (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) twice daily for 5 days. The treated area may be covered with a sterile bandage or gauze dressing if desired.
Side Effects - Adverse effects: Application site irritation (<2% of patients may experience).
Contraindications - Contraindicated in patients with hypersensitivity of any ingredient of this preparation.
Others - Pregnancy & Lactation Pregnancy Category B. It is not known whether Retapamulin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Retapamulin is administered to a nursing woman.
Retabac Ointment
- Brand Name - Retabac Ointment
- Generic Name - Retapamulin
- Doges From - Ointment
- Strength - 1% w/w
- Pack Size - 1s
- Manufacture - Square Pharmaceutical Ltd.
